vs
HELEN OF TROY LTD（HELE）与UiPath, Inc.（PATH）财务数据对比。点击上方公司名可切换其他公司
HELEN OF TROY LTD的季度营收约是UiPath, Inc.的1.2倍（$512.8M vs $411.1M），UiPath, Inc.净利率更高（48.4% vs -16.4%，领先64.8%），UiPath, Inc.同比增速更快（15.9% vs -3.4%），UiPath, Inc.自由现金流更多（$25.1M vs $5.8M），过去两年HELEN OF TROY LTD的营收复合增速更高（2.4% vs 0.7%）
海伦特洛伊是美国上市企业，主营自有及授权品牌家居用品、健康家居用品与美容产品的设计研发和全球营销，旗下拥有OXO International、Kaz等多家子公司。公司注册总部设于百慕大汉密尔顿，美国运营总部位于得克萨斯州埃尔帕索，公司名称源自古希腊神话人物特洛伊海伦。
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
HELE vs PATH — 直观对比
营收规模更大
HELE
是对方的1.2倍
$411.1M
营收增速更快
PATH
高出19.3%
-3.4%
净利率更高
PATH
高出64.8%
-16.4%
自由现金流更多
PATH
多$19.3M
$5.8M
两年增速更快
HELE
近两年复合增速
0.7%
损益表 — Q3 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $512.8M | $411.1M |
| 净利润 | $-84.1M | $198.8M |
| 毛利率 | 46.9% | 83.3% |
| 营业利润率 | -1.6% | 3.2% |
| 净利率 | -16.4% | 48.4% |
| 营收同比 | -3.4% | 15.9% |
| 净利润同比 | -269.4% | 1966.2% |
| 每股收益（稀释后） | $-3.65 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HELEPATH
| Q4 25 | $512.8M | $411.1M | ||
| Q3 25 | $431.8M | $361.7M | ||
| Q2 25 | $371.7M | $356.6M | ||
| Q1 25 | $485.9M | $423.6M | ||
| Q4 24 | $530.7M | $354.7M | ||
| Q3 24 | $474.2M | $316.3M | ||
| Q2 24 | $416.8M | $335.1M | ||
| Q1 24 | $489.2M | $405.3M |
净利润HELEPATH
| Q4 25 | $-84.1M | $198.8M | ||
| Q3 25 | $-308.6M | $1.6M | ||
| Q2 25 | $-450.7M | $-22.6M | ||
| Q1 25 | $50.9M | $51.8M | ||
| Q4 24 | $49.6M | $-10.7M | ||
| Q3 24 | $17.0M | $-86.1M | ||
| Q2 24 | $6.2M | $-28.7M | ||
| Q1 24 | $42.7M | $33.9M |
毛利率HELEPATH
| Q4 25 | 46.9% | 83.3% | ||
| Q3 25 | 44.2% | 82.2% | ||
| Q2 25 | 47.1% | 82.1% | ||
| Q1 25 | 48.6% | 84.8% | ||
| Q4 24 | 48.9% | 82.0% | ||
| Q3 24 | 45.6% | 80.0% | ||
| Q2 24 | 48.7% | 83.5% | ||
| Q1 24 | 49.0% | 86.8% |
营业利润率HELEPATH
| Q4 25 | -1.6% | 3.2% | ||
| Q3 25 | -73.1% | -5.6% | ||
| Q2 25 | -109.5% | -4.6% | ||
| Q1 25 | 0.4% | 7.9% | ||
| Q4 24 | 14.2% | -12.2% | ||
| Q3 24 | 7.3% | -32.7% | ||
| Q2 24 | 7.4% | -14.8% | ||
| Q1 24 | 13.5% | 3.7% |
净利率HELEPATH
| Q4 25 | -16.4% | 48.4% | ||
| Q3 25 | -71.5% | 0.4% | ||
| Q2 25 | -121.3% | -6.3% | ||
| Q1 25 | 10.5% | 12.2% | ||
| Q4 24 | 9.3% | -3.0% | ||
| Q3 24 | 3.6% | -27.2% | ||
| Q2 24 | 1.5% | -8.6% | ||
| Q1 24 | 8.7% | 8.4% |
每股收益（稀释后）HELEPATH
| Q4 25 | $-3.65 | $0.37 | ||
| Q3 25 | $-13.44 | $0.00 | ||
| Q2 25 | $-19.65 | $-0.04 | ||
| Q1 25 | $2.20 | $0.09 | ||
| Q4 24 | $2.17 | $-0.02 | ||
| Q3 24 | $0.74 | $-0.15 | ||
| Q2 24 | $0.26 | $-0.05 | ||
| Q1 24 | $1.76 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $27.1M | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $852.3M | $1.9B |
| 总资产 | $2.3B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HELEPATH
| Q4 25 | $27.1M | $1.4B | ||
| Q3 25 | $22.4M | $1.4B | ||
| Q2 25 | $22.7M | $1.6B | ||
| Q1 25 | $18.9M | $1.6B | ||
| Q4 24 | $40.8M | $1.6B | ||
| Q3 24 | $20.1M | $1.7B | ||
| Q2 24 | $16.1M | $1.9B | ||
| Q1 24 | $18.5M | $1.9B |
总债务HELEPATH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $921.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $672.0M | — |
股东权益HELEPATH
| Q4 25 | $852.3M | $1.9B | ||
| Q3 25 | $926.3M | $1.7B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.7B | $1.8B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.6B | $2.0B |
总资产HELEPATH
| Q4 25 | $2.3B | $2.9B | ||
| Q3 25 | $2.4B | $2.6B | ||
| Q2 25 | $2.7B | $2.6B | ||
| Q1 25 | $3.1B | $2.9B | ||
| Q4 24 | $3.0B | $2.7B | ||
| Q3 24 | $2.9B | $2.7B | ||
| Q2 24 | $2.8B | $2.8B | ||
| Q1 24 | $2.8B | $3.0B |
负债/权益比HELEPATH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.41× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.9M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | $5.8M | $25.1M |
| 自由现金流率自由现金流/营收 | 1.1% | 6.1% |
| 资本支出强度资本支出/营收 | 1.2% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.14× |
| 过去12个月自由现金流最近4个季度 | $55.9M | — |
8季度趋势，按日历期对齐
经营现金流HELEPATH
| Q4 25 | $11.9M | $28.3M | ||
| Q3 25 | $-10.5M | $41.6M | ||
| Q2 25 | $58.3M | $119.0M | ||
| Q1 25 | $35.0M | $146.1M | ||
| Q4 24 | $8.3M | $28.1M | ||
| Q3 24 | $44.6M | $46.4M | ||
| Q2 24 | $25.3M | $100.0M | ||
| Q1 24 | $73.6M | $145.6M |
自由现金流HELEPATH
| Q4 25 | $5.8M | $25.1M | ||
| Q3 25 | $-21.9M | — | ||
| Q2 25 | $45.0M | $106.2M | ||
| Q1 25 | $27.1M | $138.7M | ||
| Q4 24 | $191.0K | $23.2M | ||
| Q3 24 | $39.7M | $45.0M | ||
| Q2 24 | $16.2M | $98.8M | ||
| Q1 24 | $66.6M | $141.8M |
自由现金流率HELEPATH
| Q4 25 | 1.1% | 6.1% | ||
| Q3 25 | -5.1% | — | ||
| Q2 25 | 12.1% | 29.8% | ||
| Q1 25 | 5.6% | 32.7% | ||
| Q4 24 | 0.0% | 6.5% | ||
| Q3 24 | 8.4% | 14.2% | ||
| Q2 24 | 3.9% | 29.5% | ||
| Q1 24 | 13.6% | 35.0% |
资本支出强度HELEPATH
| Q4 25 | 1.2% | 0.8% | ||
| Q3 25 | 2.7% | 0.0% | ||
| Q2 25 | 3.6% | 3.6% | ||
| Q1 25 | 1.6% | 1.7% | ||
| Q4 24 | 1.5% | 1.4% | ||
| Q3 24 | 1.0% | 0.4% | ||
| Q2 24 | 2.2% | 0.4% | ||
| Q1 24 | 1.4% | 0.9% |
现金转化率HELEPATH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 26.25× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.69× | 2.82× | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 2.62× | — | ||
| Q2 24 | 4.08× | — | ||
| Q1 24 | 1.72× | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HELE
| Beauty Wellness | $283.2M | 55% |
| Home Outdoor | $229.6M | 45% |
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
